Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PSMB3P1 is a processed pseudogene derived from the parental proteasome subunit beta 3 (PSMB3) gene, located in the human genome, and identified as a retrocopy in primates. While retrocopies like PSMB3P1 can occasionally acquire regulatory roles or neofunctionalization unrelated to their parent genes, the majority—including PSMB3P1—are considered non-functional and do not code for proteins. No evidence supports PSMB3P1 acting as a receptor, enzyme, transporter, or other traditional therapeutic target, nor is it implicated in drug interaction or disease by itself. Functional PSMB3 (not the pseudogene) encodes a core subunit of the 20S proteasome complex, which is central to protein degradation in cells, but the pseudogene PSMB3P1 does not participate in these processes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Proteasome subunit beta 3 pseudogene 1 (PSMB3P1).